# A Study of MZE782 in Adults With PKU

> **NCT07694440** · PHASE2 · RECRUITING · sponsor: **Maze Therapeutics** · enrollment: 38 (estimated)

## Conditions studied

- Phenylketonuria (PKU)

## Interventions

- **DRUG:** MZE782
- **OTHER:** Placebo
- **DRUG:** MZE782

## Key facts

- **NCT ID:** NCT07694440
- **Lead sponsor:** Maze Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-23
- **Primary completion:** 2027-12
- **Final completion:** 2028-02
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2026-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07694440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07694440, "A Study of MZE782 in Adults With PKU". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07694440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*